Valuation: Stereotaxis Inc

Market Cap 175M 153M 141M 131M 249M 16.69B 251M 1.68B 655M 8.19B 657M 643M 28.35B P/E 2026 *
-8.95x
P/E 2027 * -11.9x
Enterprise Value 175M 153M 141M 131M 249M 16.69B 251M 1.68B 655M 8.19B 657M 643M 28.35B EV / Sales 2026 *
4.44x
EV / Sales 2027 * 3.28x
Free-Float
84.63%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 2017-02-02
Director of Finance/CFO 57 2019-09-30
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 2005-01-31
Chairman - 2017-02-02
Director/Board Member 71 2016-09-28
Change 5-day change 1-year change 3-year change Capi.($)
-7.43%-2.84% - - 175M
-1.12%+0.89%+20.56%-0.58% 195B
+1.60%+6.95%-20.50%+29.63% 151B
-2.18%-1.31%-4.71%-18.43% 140B
-1.20%+0.84%-57.25%-16.24% 67.09B
+0.86%+4.85%+23.95%+4.64% 54.34B
-0.26%+1.93%-25.36%-30.79% 44.63B
-0.11%+1.20%+8.19%+42.14% 37.24B
-0.07%-3.98%+7.60%+9.29% 36.91B
+4.18%+9.04%-15.01%+0.91% 30.24B
Average -0.33%+2.74%-6.95%+2.28% 83.99B
Weighted average by Cap. +0.15%+3.44%-4.36%+1.99%

Financials

2026 *2027 *
Net sales 39.4M 34.43M 31.72M 29.42M 55.97M 3.76B 56.64M 379M 148M 1.84B 148M 145M 6.39B 53.28M 46.56M 42.89M 39.78M 75.68M 5.08B 76.58M 512M 199M 2.49B 200M 196M 8.63B
Net income -19.4M -16.95M -15.62M -14.49M -27.56M -1.85B -27.89M -186M -72.63M -908M -72.85M -71.25M -3.14B -13.62M -11.91M -10.97M -10.17M -19.35M -1.3B -19.59M -131M -51.01M -638M -51.16M -50.04M -2.21B
Net Debt - -
Logo Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-